Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Pitts

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Clinical Neuropharmacology|January 1, 1986
Noradrenergic and cholinergic agents in Korsakoff's syndromeV M O'Donnell, W M Pitts, W E Fann
Pharmacotherapy|March 1, 1982
Pharmacology, efficacy, and adverse effects of halazepam, a new benzodiazepineW E Fann, W M Pitts, J C Wheless
The Journal of Clinical Psychiatry|June 1, 1983
Alprazolam in older depressed inpatientsW M Pitts, W E Fann, C Sajadi, et al.
The American Journal of Psychiatry|June 1, 1982
Identifying the depressive border of the borderline personality disorderS Snyder, C Sajadi, W M Pitts, et al.
The Journal of Nervous and Mental Disease|October 1, 1985
MMPI critical item characteristics of the DSM-III borderline personality disorderW M Pitts, Q L Gustin, C Mitchell, et al.
Psychopathology|January 1, 1984
Family structure as recalled by borderline patientsS Snyder, W M Pitts, W A Goodpaster, et al.
The American Journal of Psychiatry|August 1, 1982
MMPI profile of DSM-III borderline personality disorderS Snyder, W M Pitts, W A Goodpaster, et al.
Psychopathology|January 1, 1985
Demography of psychiatric patients with borderline personality traitsS Snyder, W A Goodpaster, W M Pitts, et al.
Clinical Pharmacology and Therapeutics|October 1, 1983
Multiple-dose doxepin kinetics in depressed patientsR D Faulkner, W M Pitts, C S Lee, et al.
Neuropsychobiology|January 1, 1997
Plasma alpha-one acid glycoprotein and haloperidol concentrations in schizophrenic patientsM W Jann, B L Crabtree, W M Pitts, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical Neuropharmacology|January 1, 1986
Noradrenergic and cholinergic agents in Korsakoff's syndromeV M O'Donnell, W M Pitts, W E Fann
Pharmacotherapy|March 1, 1982
Pharmacology, efficacy, and adverse effects of halazepam, a new benzodiazepineW E Fann, W M Pitts, J C Wheless
The Journal of Clinical Psychiatry|June 1, 1983
Alprazolam in older depressed inpatientsW M Pitts, W E Fann, C Sajadi, et al.
The American Journal of Psychiatry|June 1, 1982
Identifying the depressive border of the borderline personality disorderS Snyder, C Sajadi, W M Pitts, et al.
The Journal of Nervous and Mental Disease|October 1, 1985
MMPI critical item characteristics of the DSM-III borderline personality disorderW M Pitts, Q L Gustin, C Mitchell, et al.
Psychopathology|January 1, 1984
Family structure as recalled by borderline patientsS Snyder, W M Pitts, W A Goodpaster, et al.
The American Journal of Psychiatry|August 1, 1982
MMPI profile of DSM-III borderline personality disorderS Snyder, W M Pitts, W A Goodpaster, et al.
Psychopathology|January 1, 1985
Demography of psychiatric patients with borderline personality traitsS Snyder, W A Goodpaster, W M Pitts, et al.
Clinical Pharmacology and Therapeutics|October 1, 1983
Multiple-dose doxepin kinetics in depressed patientsR D Faulkner, W M Pitts, C S Lee, et al.
Neuropsychobiology|January 1, 1997
Plasma alpha-one acid glycoprotein and haloperidol concentrations in schizophrenic patientsM W Jann, B L Crabtree, W M Pitts, et al.
Pageof 3